Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain; including traumatic brain injury (TBI) and amblyopia (lazy eye). NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible.
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $8.7M
Founded date: 2009
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.10.2019 | - | $8.7M | - |
Mentions in press and media 1
| Date | Title | Description |
| 25.08.2017 | Boston Tech Watch: Rethink Robotics, SquadLocker, Semcasting & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints There was a flurry of tech deals announced this week in Boston, including the acquisitions of Applause, Digital Lumens, and Dragon Innovation, and a $6 million investment in G... |